Healthcare provider profile · identity verified

Melissa Johnson Bertelson, NP-C

Nurse Practitioner · ALBERT LEA, MN · NPI 1932675352

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	550	186
Levothyroxine Sodium	Levothyroxine Sodium	453	128
Lisinopril	Lisinopril	445	139
Amlodipine Besylate	Amlodipine Besylate	425	127
Losartan Potassium	Losartan Potassium	355	116
Simvastatin	Simvastatin	296	94
Metoprolol Succinate	Metoprolol Succinate	294	105
Omeprazole	Omeprazole	294	97
Gabapentin	Gabapentin	226	71
Metoprolol Tartrate	Metoprolol Tartrate	218	71
Metformin Hcl Er	Metformin Hcl	201	71
Rosuvastatin Calcium	Rosuvastatin Calcium	201	70
Pantoprazole Sodium	Pantoprazole Sodium	189	61
Sertraline Hcl	Sertraline Hcl	168	49
Hydrochlorothiazide	Hydrochlorothiazide	166	60
Furosemide	Furosemide	156	60
Pravastatin Sodium	Pravastatin Sodium	127	41
Metformin Hcl	Metformin Hcl	124	46
Eliquis	Apixaban	114	31
Warfarin Sodium	Warfarin Sodium	101	31
Tamsulosin Hcl	Tamsulosin Hcl	99	35
Trazodone Hcl	Trazodone Hcl	99	32
Spironolactone	Spironolactone	89	26
Buspirone Hcl	Buspirone Hcl	88	24
Allopurinol	Allopurinol	86	28
Fluticasone Propionate	Fluticasone Propionate	86	40
Venlafaxine Hcl Er	Venlafaxine Hcl	86	17
Duloxetine Hcl	Duloxetine Hcl	82	26
Potassium Chloride	Potassium Chloride	81	24
Atenolol	Atenolol	77	19
Carvedilol	Carvedilol	76	26
Oxybutynin Chloride Er	Oxybutynin Chloride	74	14
Glipizide Er	Glipizide	72	21
Montelukast Sodium	Montelukast Sodium	71	21
Escitalopram Oxalate	Escitalopram Oxalate	69	22
Famotidine	Famotidine	69	26
Zolpidem Tartrate	Zolpidem Tartrate	68	18
Topiramate	Topiramate	65	11
Citalopram Hbr	Citalopram Hydrobromide	64	17
Diclofenac Sodium	Diclofenac Sodium	64	17
Lorazepam	Lorazepam	61	21
Prednisone	Prednisone	61	34
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	17
Albuterol Sulfate Hfa	Albuterol Sulfate	54	29
Fluoxetine Hcl	Fluoxetine Hcl	53	18
Xarelto	Rivaroxaban	50	17
Chlorthalidone	Chlorthalidone	49	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	48	15
Alendronate Sodium	Alendronate Sodium	46	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	46	14
Jardiance	Empagliflozin	46	17
Clonazepam	Clonazepam	45	suppressed
Levetiracetam	Levetiracetam	45	suppressed
Ventolin Hfa	Albuterol Sulfate	44	14
Bupropion Xl	Bupropion Hcl	41	15
Torsemide	Torsemide	41	14
Ketoconazole	Ketoconazole	38	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	38	14
Clopidogrel	Clopidogrel Bisulfate	37	16
Carbamazepine Er	Carbamazepine	36	suppressed
Alprazolam	Alprazolam	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Glimepiride	Glimepiride	34	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	11
Sumatriptan Succinate	Sumatriptan Succinate	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	11
Estradiol	Estradiol	29	12
Hydroxyzine Hcl	Hydroxyzine Hcl	29	16
Mirtazapine	Mirtazapine	27	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	25	suppressed
Ozempic	Semaglutide	25	suppressed
Lansoprazole	Lansoprazole	24	suppressed
Pregabalin	Pregabalin	24	12
Cefdinir	Cefdinir	23	18
Ezetimibe	Ezetimibe	23	suppressed
Finasteride	Finasteride	23	12
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	22	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	11
Methimazole	Methimazole	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Tramadol Hcl	Tramadol Hcl	19	suppressed
Naproxen	Naproxen	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	17	suppressed
Diazepam	Diazepam	17	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	17	suppressed
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	17	17
Lovastatin	Lovastatin	17	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Mometasone Furoate	Mometasone Furoate	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Baclofen	Baclofen	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Valsartan	Valsartan	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	14	suppressed
Levocarnitine	Levocarnitine (With Sugar)	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	12
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Sodium Chloride	Sodium Chloride Irrig Solution	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	11
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Colesevelam Hcl	Colesevelam Hcl	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Nitroglycerin	Nitroglycerin	12	11
Peg-3350 And Electrolytes	Peg3350/Sod Sulf,bicarb,cl/Kcl	12	12
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error